TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.25 by 180 percent. This is a 100 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $143.54 million which beat the analyst consensus estimate of $123.66 million by 16.07 percent. This is a 48.21 percent increase over sales of $96.85 million the same period last year.